NCT03558425View on ClinicalTrials.gov

A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 27, 2018

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
GERD
Interventions
DRUG

CKD-381

1 tablet administered before the breakfast during 7 days

DRUG

D026

1 tablet administered before the breakfast during 7 days

Trial Locations (1)

Unknown

Seoul Nat'l University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY